Sodium Iodide (CAS NO : 7681-82-5)

Sodium Iodide (CAS No: 7681-82-5) is currently experiencing a strategic pivot in the global speciality chemicals market, primarily driven by its indispensable role in the burgeoning nuclear medicine sector where it serves as the foundational precursor for radioisotopes used in high-precision thyroid diagnostics and therapeutic oncology. Beyond its pharmaceutical utility, the compound is witnessing a surge in industrial demand as a high-performance nucleophile in Finkelstein reactions, facilitating the efficient synthesis of complex alkyl iodides and API intermediates within the CDMO sector, particularly for the production of anti-infectives and anaesthetics. Furthermore, its application in scintillation detectors for radiation monitoring is becoming increasingly critical as global energy strategies shift towards nuclear power, necessitating high-purity crystalline grades that offer superior light yield and energy resolution for sophisticated detection hardware. As globally established Sodium Iodide supplier with Sodium Iodide purity %. We ensure dependable supply, consistent quality, and complete regulatory documentation, including Sodium Iodide CoA and Sodium Iodide TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.